MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells
- PMID: 15197348
- DOI: 10.4161/cbt.3.8.968
MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells
Abstract
We examined the impact of purified bacterially synthesized GST-MDA-7 (IL-24) and ionizing radiation on the proliferation and survival of nonestablished human glioblastoma multiforme (GBM) cells. Glioma cell types expressing mutated PTEN and p53 molecules, activated ERBB1VIII, overexpressing wild type ERBB1 or without receptor overexpression were selected. In MTT assays, GST-MDA-7 caused a dose-dependent reduction in the proliferation of nonestablished glioma cells; however only at higher concentrations did GST-MDA-7 reduce cell viability. The anti-proliferative and cytotoxic effects of GST-MDA-7 were enhanced by radiation in a greater than additive fashion that correlated with JNK1/2/3 activation. The reduction in cell growth and enhancement in cell killing by the combination of GST-MDA-7 and radiation were blocked by an ROS scavenger, N-acetyl cysteine (NAC), a JNK1/2/3 inhibitor SP600125, a pan-caspase inhibitor (zVAD) and by an inhibitor of caspase 9 (LEHD), but not by an inhibitor of caspase 8 (IETD). Low concentrations of either GST-MDA-7 or radiation reduced clonogenic survival, however colony formation ability was significantly further decreased when the two treatments were combined, which was also blocked by inhibition of caspase 9 function. In general agreement with activation of the intrinsic caspase pathway, cell death correlated with reduced BCL-XL expression and with increased levels of the pro-apoptotic proteins BAD and BAX. Inhibition of caspase 9 after combination treatment blunted neither JNK1/2/3 activation nor the enhanced expression of BAD and BAX, but did block caspase 3 cleavage, reduced expression of BCL-XL and inhibition of ERK1/2 activity. In contrast, incubation with NAC blocked JNK1/2/3 activation and cell killing, but not the increases in BAD and BAX expression. These findings argue that after combination treatment JNK1/2/3 activation is a primary pro-apoptotic event and loss of BCL-XL expression and ERK1/2 activity are secondary caspase-dependent processes. This data also argues that GST- MDA-7 induces two parallel pro-apoptotic pathways via ROS-dependent and -independent mechanisms. Infection of primary human astrocytes with a recombinant adenovirus to express MDA-7, Ad.mda-7, but not infection with either Ad.cmv or Ad.mda-7SP- lacking MDA-7 secretion, resulted in the suppression of GBM cell colony formation in soft agar overlay assays, an effect that was enhanced in a greater than additive fashion by radiation. Collectively, our findings demonstrate that MDA-7 reduces proliferation and enhances the radiosensitivity of nonestablished human GBM cells in vitro, and when grown in 3 dimensions, and that sensitization occurs independently of basal EGFR/ERK1/2/AKT activity or the functions of PTEN and p53.
Comment in
-
Potential use of MDA-7 as a biological adjuvant for radiation therapy.Cancer Biol Ther. 2004 Aug;3(8):752-4. doi: 10.4161/cbt.3.8.1029. Epub 2004 Aug 15. Cancer Biol Ther. 2004. PMID: 15326389 No abstract available.
Similar articles
-
mda-7 (IL-24) Inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling.Cancer Biol Ther. 2003 Jul-Aug;2(4):347-53. doi: 10.4161/cbt.2.4.422. Cancer Biol Ther. 2003. PMID: 14508103
-
Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo.Clin Cancer Res. 2003 Aug 15;9(9):3272-81. Clin Cancer Res. 2003. PMID: 12960112
-
MDA-7 (interleukin-24) inhibits the proliferation of renal carcinoma cells and interacts with free radicals to promote cell death and loss of reproductive capacity.Mol Cancer Ther. 2003 Jul;2(7):623-32. Mol Cancer Ther. 2003. PMID: 12883035
-
Apoptosis - the p53 network.J Cell Sci. 2003 Oct 15;116(Pt 20):4077-85. doi: 10.1242/jcs.00739. J Cell Sci. 2003. PMID: 12972501 Review.
-
Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.Cell Cycle. 2011 Jan 1;10(1):33-8. doi: 10.4161/cc.10.1.14365. Epub 2011 Jan 1. Cell Cycle. 2011. PMID: 21200141 Free PMC article. Review.
Cited by
-
Myeloid cells migrate in response to IL-24.Cytokine. 2011 Sep;55(3):429-34. doi: 10.1016/j.cyto.2011.05.018. Epub 2011 Jun 23. Cytokine. 2011. PMID: 21703864 Free PMC article.
-
Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts.Cancer Res. 2009 Sep 1;69(17):6915-23. doi: 10.1158/0008-5472.CAN-09-0664. Cancer Res. 2009. PMID: 19723667 Free PMC article.
-
PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells.Cancer Res. 2010 Feb 1;70(3):1120-9. doi: 10.1158/0008-5472.CAN-09-4043. Epub 2010 Jan 26. Cancer Res. 2010. PMID: 20103619 Free PMC article.
-
IL-24 intrinsically regulates Th17 cell pathogenicity in mice.J Exp Med. 2022 Aug 1;219(8):e20212443. doi: 10.1084/jem.20212443. Epub 2022 Jul 12. J Exp Med. 2022. PMID: 35819408 Free PMC article.
-
Enhancing CHK1 inhibitor lethality in glioblastoma.Cancer Biol Ther. 2012 Apr;13(6):379-88. doi: 10.4161/cbt.19240. Epub 2012 Apr 1. Cancer Biol Ther. 2012. PMID: 22313687 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous